Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain
- PMID: 16883178
- DOI: 10.1227/01.NEU.0000222658.66878.CC
Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain
Abstract
Objective: Neoangiogenesis is a prerequisite for the full phenotypic expression and growth of a malignant tumor mass. It is believed to be triggered by tissue hypoxia and involves proliferation and sprouting of the preexisting vessels and the recruitment of endothelial progenitor cells from bone marrow.
Methods: A chimeric mouse model was used to examine the contribution of these progenitor cells to the neovasculature of brain tumor. T-cell knockout (RAG/KO5.2) mice were irradiated lethally, and their bone marrow was repopulated with T-cell depleted green fluorescent protein (GFP)-expressing bone marrow cells. RAG/RT-2 glioma cells were implanted into the striatum of the animals. Neovascular formation at various times of tumor growth was monitored together with the extent of incorporation of GFP+ bone marrow-derived cells within the vascular tree, in particular, cells carrying the endothelial progenitor markers CD34 and Flk-1.
Results: The recruitment of GFP+ cells to the growing tumor and their incorporation into the vascular network occurred during the period of increasing vascular density and preceded the expansion of the tumor. The number of marrow-derived cells with endothelial morphology and phenotype was small but significant (4% of all endothelial cells at Day 12); 54% of all tumor vessels contained at least one GFP+ cell.
Conclusion: Our results suggest that bone marrow cells are recruited to newly formed and remodeled tumor vessels. Their recruitment may occur in response to signals from a highly proliferating milieu, and their role is to support the neovascular complex and to promote tumor growth.
Similar articles
-
Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice.Clin Cancer Res. 2001 Sep;7(9):2870-9. Clin Cancer Res. 2001. PMID: 11555605
-
Endothelial progenitor cells are recruited into resolving venous thrombi.Circulation. 2005 May 24;111(20):2645-53. doi: 10.1161/CIRCULATIONAHA.104.492678. Epub 2005 May 9. Circulation. 2005. PMID: 15883207
-
Bone marrow-derived cells do not incorporate into the adult growing vasculature.Circ Res. 2004 Feb 6;94(2):230-8. doi: 10.1161/01.RES.0000110419.50982.1C. Epub 2003 Dec 4. Circ Res. 2004. PMID: 14656934
-
Endothelial progenitor cells as a new agent contributing to vascular repair.Arch Immunol Ther Exp (Warsz). 2007 Jul-Aug;55(4):247-59. doi: 10.1007/s00005-007-0027-5. Epub 2007 Jul 23. Arch Immunol Ther Exp (Warsz). 2007. PMID: 17659378 Review.
-
The bone marrow constitutes a reservoir of pericyte progenitors.J Leukoc Biol. 2006 Oct;80(4):677-81. doi: 10.1189/jlb.0506309. Epub 2006 Aug 3. J Leukoc Biol. 2006. PMID: 16888086 Review.
Cited by
-
Stromal-cell-derived Factor 1-α Promotes Tumor Progression in Colorectal Cancer.J Korean Soc Coloproctol. 2012 Feb;28(1):27-34. doi: 10.3393/jksc.2012.28.1.27. Epub 2012 Feb 29. J Korean Soc Coloproctol. 2012. PMID: 22413079 Free PMC article.
-
Neoplastic cells are a rare component in human glioblastoma microvasculature.Oncotarget. 2012 Jan;3(1):98-106. doi: 10.18632/oncotarget.427. Oncotarget. 2012. PMID: 22298889 Free PMC article. Review.
-
Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger.Blood. 2009 Nov 5;114(19):4310-9. doi: 10.1182/blood-2009-03-211342. Epub 2009 Aug 28. Blood. 2009. PMID: 19717647 Free PMC article.
-
Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft.J Neurooncol. 2009 Jun;93(2):165-74. doi: 10.1007/s11060-008-9757-4. Epub 2008 Dec 4. J Neurooncol. 2009. PMID: 19052696
-
Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.Int J Cancer. 2008 Aug 15;123(4):831-7. doi: 10.1002/ijc.23582. Int J Cancer. 2008. PMID: 18537159 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical